• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I HBSAG CONFIRMATORY V.1 REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I HBSAG CONFIRMATORY V.1 REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 08P09-22
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/21/2024
Event Type  malfunction  
Manufacturer Narrative
All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 8p09 that has a similar product distributed in the us, list number 4p54.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed a false negative alinity i hbsag confirmatory result for a patient who was repeatedly reactive when tested with the hbsag screening assay.The following data was provided for the confirmatory testing: undiluted reagent2 = 1.37 s/co neutralization rate = 19.37% 500-fold diluted reagent2 = 0.79 s/co neutralization rate = 76.32% the customer was questioning the negative 500-fold dilution results.The customer was expecting the patient's confirmatory testing to be confirmed positive because the patient was repeatedly reactive when tested with the screening assay.There is no impact to patient management reported.
 
Manufacturer Narrative
The complaint investigation for false negative alinity i hbsag confirmatory results included a search for similar complaints, and the review of complaint text, trending data, labeling, and device history records.Return testing was not performed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.Ticket tracking and trending was reviewed for the list number and did not identify any trends regarding the commonalities for the complaint issue.The device history record was reviewed and did not identify any non-conformances, potential non-conformances, or deviations associated with the list number and complaint issue.Labeling was reviewed and adequately addresses the issue under review.Based on the investigation, no systemic issue or product deficiency was identified for the alinity i hbsag confirmatory reagent kit list number 08p09-22, lot unknown.
 
Event Description
The customer observed a false negative alinity i hbsag confirmatory result for a patient who was repeatedly reactive when tested with the hbsag screening assay.The following data was provided for the confirmatory testing: undiluted reagent2 = 1.37 s/co neutralization rate = 19.37% 500-fold diluted reagent2 = 0.79 s/co neutralization rate = 76.32% the customer was questioning the negative 500-fold dilution results.The customer was expecting the patient's confirmatory testing to be confirmed positive because the patient was repeatedly reactive when tested with the screening assay.There is no impact to patient management reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I HBSAG CONFIRMATORY V.1 REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key19043417
MDR Text Key340115842
Report Number3008344661-2024-00041
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00380740130503
UDI-Public(01)00380740130503
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number08P09-22
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/21/2024
Initial Date FDA Received04/04/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/19/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, (B)(6); ALNTY I PROCESSING MODU, 03R65-01, (B)(6).
-
-